Edwin Ofori Atta on Permissive Hypertension For Ischemic Stroke
Edwin Ofori Atta, Head Of Pharmacy at Kumasi Hospital, shared on LinkedIn:
”Permissive Hypertension For Ischemic Stroke
In 2026, permissive hypertension remains a standard temporary management strategy for acute ischemic stroke.
It involves intentionally allowing a patient’s blood pressure (BP) to remain elevated to ensure adequate blood flow to the ischemic penumbra—the salvageable brain tissue surrounding the core area of the stroke.
It’s purposely done to maximize cerebral perfusion and promote collateral circulation when the brain’s natural autoregulation of blood flow is impaired.
It’s typically maintained for the first 24hrs to 48hrs following stroke onset.
It’s Primarily candidates are patients with acute ischemic stroke who are not candidates for immediate reperfusion therapies (like “clot-busting” drugs) or those whose BP is high but below dangerous thresholds (<220/120 mmHg)”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency